Pictet Asset Management (Switzerland)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$52.7M Sell
598,589
-18,011
-3% -$1.55M 0.06% 283
2023
Q1
$49.7M Sell
616,600
-297,930
-33% -$24.3M 0.06% 284
2022
Q4
$71.1M Sell
914,530
-68,556
-7% -$5.56M 0.1% 225
2022
Q3
$79.4M Buy
983,086
+70,475
+8% +$6.33M 0.12% 215
2022
Q2
$81.9M Sell
912,611
-84,470
-8% -$8.56M 0.11% 215
2022
Q1
$111M Buy
997,081
+231,777
+30% +$24.5M 0.13% 204
2021
Q4
$79.2M Buy
765,304
+6,494
+0.9% +$752K 0.08% 264
2021
Q3
$95.1M Buy
+758,810
New +$98.2M 0.1% 232

Other funds holding MDT

Pictet Asset Management (Switzerland)'s MDT Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Medtronic (MDT) stake by 2.9% in Q2 2023, selling an estimated $1.55M and leaving 598,589 shares worth $52.7M. The position accounts for 0.06% of the portfolio, ranked #283.

Pictet Asset Management (Switzerland) first reported a position in MDT in Q3 2021 and has held it in 8 quarters since. The position peaked at $111M in Q1 2022. 2,057 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 598,589 shares of Medtronic worth $52.7M as of Q2 2023.
  • Pictet Asset Management (Switzerland) sold 18,011 Medtronic shares in Q2 2023, an estimated $1.55M.
  • Medtronic made up 0.06% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #283 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Medtronic in Q3 2021 and has held it in 8 quarters since.
  • Pictet Asset Management (Switzerland)'s Medtronic position peaked at $111M in Q1 2022.
  • 2,057 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.